Education
About Us
Working with TipRanks
Follow Us
Tactic Pharma LLC Insider Profile
4 Followers
Tactic Pharma LLC, Ten Percent Owner at Monopar Therapeutics Inc, holds 822.25K shares in Monopar Therapeutics Inc (Ticker: MNPR). Most recently, Tactic Pharma LLC Sold 33,334 shares of Monopar Therapeutics Inc on Apr 04, 2025 for an estimated value of $1.17M.
Tactic Pharma LLC Monopar Therapeutics Inc (MNPR)Ten Percent Owner
Monopar Therapeutics Inc (MNPR)
Ten Percent Owner
Ranked #82,497 out of 103,225 Corporate Insiders
Profitable Transactions
0 out of 2 Profitable Transactions
Average Return
-42.80%
Average return per transaction
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Tactic Pharma LLC's holdings
Insider Roles
Ten Percent Owner
Roles that Tactic Pharma LLC holds in companies
Most Profitable Insider Trade
The most profitable trade made by Tactic Pharma LLC
Tactic Pharma LLC's Trading History
List of latest transactions for each holding click on a transaction to see Tactic Pharma LLC's performance on stock
You May Also Like
Tactic Pharma LLC insider profile FAQ
What is the percentage of profitable transactions made by Tactic Pharma LLC?
The percentage of profitable transactions made by Tactic Pharma LLC is 0%.
What is the average return per transaction made by Tactic Pharma LLC?
The average return per transaction made by Tactic Pharma LLC is -42.80%.
What stocks does Tactic Pharma LLC hold?
Tactic Pharma LLC holds: MNPR stocks.
What was Tactic Pharma LLC’s latest transaction?
Tactic Pharma LLC latest transaction was an Informative Sell of $1.17M.
What was Tactic Pharma LLC's most profitable transaction?
Tactic Pharma LLC’s most profitable transaction was an Informative Sell of MNPR stock on April 4, 2025. The return on the trade was -6.80%.
What is Tactic Pharma LLC's role in Monopar Therapeutics Inc?
Tactic Pharma LLC's role in Monopar Therapeutics Inc is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.